Lortab /00607101/


Indications and Reactions:

Role Indications Reactions
Primary
Back Pain 100.0%
Surgery 100.0%
Secondary
Product Used For Unknown Indication 53.2%
Drug Abuse 11.0%
Pain 9.2%
Back Pain 5.5%
Accidental Exposure To Product By Child 2.8%
Hypertension 2.8%
Analgesic Therapy 1.8%
Atrial Fibrillation 1.8%
Muscle Spasms 1.8%
Arthralgia 0.9%
Breakthrough Pain 0.9%
Breast Cancer 0.9%
Drug Detoxification 0.9%
Hyperlipidaemia 0.9%
Hypersensitivity 0.9%
Multiple Sclerosis 0.9%
Neck Pain 0.9%
Neuropathy Peripheral 0.9%
Osteoporosis Postmenopausal 0.9%
Substance Abuse 0.9%
Drug Abuse 16.7%
Vestibular Disorder 8.3%
Accidental Overdose 4.2%
Acute Hepatic Failure 4.2%
Completed Suicide 4.2%
Confusional State 4.2%
Death 4.2%
Dizziness 4.2%
Drug Withdrawal Syndrome 4.2%
Gastrooesophageal Reflux Disease 4.2%
Incorrect Dose Administered 4.2%
Liver Injury 4.2%
Loss Of Consciousness 4.2%
Memory Impairment 4.2%
Myocardial Infarction 4.2%
Nerve Injury 4.2%
Pain 4.2%
Product Adhesion Issue 4.2%
Rash 4.2%
Respiratory Arrest 4.2%
Concomitant
Product Used For Unknown Indication 65.1%
Pain 7.8%
Hepatitis C 3.9%
Rheumatoid Arthritis 3.8%
Back Pain 2.3%
Breakthrough Pain 2.3%
Hypertension 1.9%
Premedication 1.8%
Arthralgia 1.4%
Type 2 Diabetes Mellitus 1.4%
Anxiety 1.1%
Nausea 1.1%
Gastrooesophageal Reflux Disease 1.0%
Multiple Sclerosis 0.9%
Psoriatic Arthropathy 0.8%
Gout 0.7%
Insomnia 0.7%
Osteoporosis Postmenopausal 0.7%
Lung Neoplasm Malignant 0.6%
Psoriasis 0.6%
Drug Ineffective 13.0%
Vomiting 10.0%
Sinusitis 8.0%
Inadequate Analgesia 6.0%
Pain 6.0%
Pneumonia 6.0%
Therapeutic Response Decreased 6.0%
Wrong Technique In Drug Usage Process 5.0%
Nausea 4.0%
Psoriasis 4.0%
Rash 4.0%
Urinary Tract Infection 4.0%
Convulsion 3.0%
Death 3.0%
Drug Effect Decreased 3.0%
Injection Site Warmth 3.0%
Malaise 3.0%
Pain In Extremity 3.0%
Spinal Fusion Surgery 3.0%
Weight Decreased 3.0%

Drug Data